Ronald Kirk Huntsman
Chief Executive Officer at Vivos Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Vivos Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Vivos Therapeutics Inc. November 4, 202593.0%
-
Vivos Therapeutics Inc. September 25, 202366.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | Vivos Therapeutics Inc. | Other | +85,910 | $0.58 | $49,828 |
| Jun 20, 2023 | Vivos Therapeutics Inc. | Open-market purchase | +14,000 | $0.53 | $7,420 |
| Jun 16, 2023 | Vivos Therapeutics Inc. | Open-market purchase | +10,000 | $0.54 | $5,400 |
| Jun 16, 2023 | Vivos Therapeutics Inc. | Open-market purchase | +5,000 | $0.53 | $2,650 |
| Jun 15, 2023 | Vivos Therapeutics Inc. | Open-market purchase | +21 | $0.50 | $11 |
| Jun 14, 2023 | Vivos Therapeutics Inc. | Open-market purchase | +10,000 | $0.49 | $4,900 |
Questions about Ronald Kirk Huntsman
What boards is Ronald Kirk Huntsman on?
Ronald Kirk Huntsman sits on the board of Vivos Therapeutics Inc.
What company is Ronald Kirk Huntsman the CEO of?
Ronald Kirk Huntsman is Chief Executive Officer of Vivos Therapeutics Inc.
How long has Ronald Kirk Huntsman served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.